Researchers identify two key proteins that allow chandelier cells to connect with excitatory neurons. This "handshake" regulates brain signals and, when disrupted, may lead to epilepsy or autism.

Scientists have discovered a new way to advance drug discovery and diagnostics by targeting a part of the proteome (the complete set of proteins in an organism) that was previously thought ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...

Scientists at Johns Hopkins have uncovered a surprising new way to influence brain activity by targeting a long-mysterious class of proteins linked to anxiety, schizophrenia, and movement disorders.

A selective protein degradation system known as Golgi membrane-associated degradation (GOMED), which identifies and removes ...

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...

Avenue Biosciences technology collects data sets on how specific signal peptides impact specific protein targets.

Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...

Scientists reveal the GluD brain protein's active role, offering new hope for mental health. Discover how this breakthrough ...